FDA Inspection
Fairfax Cryobank Inc - FairfaxFairfax Cryobank Inc - Fairfax – FDA Inspection, Mar 20, 2019
Record Details
This FDA Inspection record concerns Fairfax Cryobank Inc - Fairfax, with an inspection on March 20, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 9bf7a477-56a9-4aa2-8e4d-0438a705ba56
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1083931
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 1271.55(d)(1)(iii)Documentation--determination, by whom, date
- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.47(a)Procedures for all other requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fairfax Cryobank Inc - Fairfax
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2025 | Not classified | Baltimore District Office | |
| August 24, 2023 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 1, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 28, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Fairfax Cryobank Inc - Fairfax
- FDA Inspection 1268297 - 2025-04-24
- FDA Inspection 1216117 - 2023-08-24
- FDA Inspection 996121 - 2016-12-01
- FDA Inspection 798105 - 2012-08-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.